Selected phlebological abstracts.

The authors conducted a review of the literature available in order to better understand the premise that, in addition to best medical practice (BMP), including anticoagulation, compression, exercise, and skin care, antiplatelet agents may also be helpful in minimizing the risk of post thrombotic syndrome (PTS) and pulmonary embolism (PE). The authors concluded that in chronic deep vein thrombosis (DVT) following initial standard treatment with anticoagulants, there is low certainty evidence that antiplatelets in addition to BPM may reduce recurrent venous thromboembolism compared to BPM + placebo. There is no discernable increase in adverse events in patients treated with BPM + antiplatelet agents. The authors suggest further study.